• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

    12.88 -0.01 (-0.04%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,500
    Open 12.88
    Bid (Size) 12.87 (100)
    Ask (Size) 13.00 (100)
    Prev. Close 12.88
    Today's Range 12.88 - 12.88
    52wk Range 7.070 - 15.42
    Shares Outstanding 1,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    3 Profitable Stocks with Open Questions
    Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
    Via StockStory
    Topics Economy

    Performance

    YTD
    +1.7%
    +1.7%
    1 Month
    -1.8%
    -1.8%
    3 Month
    -3.2%
    -3.2%
    6 Month
    +5.7%
    +5.7%
    1 Year
    +72.8%
    +72.8%

    More News

    Read More
    News headline image
    Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    2 Reasons AMRX is Risky and 1 Stock to Buy Instead
    Via StockStory
    Topics Artificial Intelligence Stocks
    News headline image
    Amneal Reports First Quarter 2026 Financial Results
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    Amneal (AMRX) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Amneal (AMRX) Q2 2025 Earnings Transcript ↗
    Via The Motley Fool
    Topics Supply Chain
    News headline image
    1 Value Stock to Target This Week and 2 Facing Challenges
    Via StockStory
    News headline image
    Amneal (AMRX) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Amneal (AMRX) Q1 Earnings Report Preview: What To Look For
    Via StockStory
    News headline image
    Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader
    From Kashiv BioSciences, LLC
    Via Business Wire
    News headline image
    Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    2 Cash-Producing Stocks to Research Further and 1 We Brush Off
    Via StockStory
    News headline image
    Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    3 of Wall Street’s Favorite Stocks We Steer Clear Of
    Via StockStory
    News headline image
    Amneal to Report First Quarter 2026 Results on May 1, 2026
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    3 Small-Cap Stocks Walking a Fine Line
    Via StockStory
    News headline image
    Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    3 Reasons to Avoid AMRX and 1 Stock to Buy Instead
    Via StockStory
    Topics Stocks
    News headline image
    3 Value Stocks We’re Skeptical Of
    Via StockStory

    Frequently Asked Questions

    Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
    Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
    What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?
    Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?
    The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market
    What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
    The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 12.88
    When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?
    The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 06/03/26 04:00 PM ET
    What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
    The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 12.88K
    How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
    Amneal Pharmaceuticals, Inc. - Class A Common Stock has 13K shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.